发明名称 Heteroaryl succinamides and their use as metalloproteinase inhibitors
摘要 The specification describes compounds of the formula I: wherein X is a single bond or a straight or branched, saturated or unsaturated chain containing 1 to 6 carbon atoms, wherein one or more of the carbon atoms are optionally independently replaced with O or S, and wherein one or more of the hydrogen atoms are optionally replaced with F; Y is a single bond, --CH(OH)--, or --C(O)--; R1 is H, an alkyl group, an aryl group, a heteroaryl group, a cycloalkyl group, or a heterocycloalkyl group; R2 is H, an alkyl group, an aryl group, a heteroaryl group, a cycloalkyl group, a heterocycloalkyl group, or C(O)R10 wherein R10 is H, an O-alkyl group, an alkyl group, an aryl group, a heteroaryl group, a cycloalkyl group, a heterocycloalkyl group, an O-aryl group, an O-alkyl group, or NR11 R12 ; wherein R11 is H, an alkyl group, an O-alkyl group, an aryl group, a heteroaryl group, a cycloalkyl group, or a heterocycloalkyl group, and wherein R12 is H, an alkyl group, an aryl group, a heteroaryl group, a cycloalkyl group, or a heterocycloalkyl group, or wherein R11 and R12 form, together with the nitrogen to which they are attached, a heteroaryl group or a heterocycloalkyl group; and R3 is H, an alkyl group, an aryl group, a heteroaryl group, a cycloalkyl group, a heterocycloalkyl group, NR11 R12, or OR11, wherein R11 and R12 are as defined above, or R2 and R3, together with the atom(s) to which they are attached, form a cycloalkyl group or a heterocycloalkyl group; R4 is H or any suitable organic moiety; R5 is C(O)NHOH, C(O)OR13, SH, N(OH)CHO, SC(O)R14, P(O)(OH)R15, or P(O)(OH)OR13 ; R13 is H, an alkyl group, or an aryl group, R14 is an alkyl group or an aryl group, and R15 is an alkyl group; and is a heteroaryl group having five ring atoms, including 1, 2 or 3 heteroatoms selected from O, S, and N. Methods of inhibiting matrix metalloproteinase activity that comprise contacting the protease with an effective amount of a compound of formula I or a pharmaceutically acceptable prodrug or a pharmaceutically acceptable salt or solvate thereof are also described
申请公布号 NZ334886(A) 申请公布日期 2000.11.24
申请号 NZ19970334886 申请日期 1997.10.06
申请人 SYNTEX (USA) INC 发明人 BENDER, STEVEN L;CASTELHANO, ARLINDO L;CHONG, WESLEY K M;ABREO, MELWYN A;BILLEDEAU, ROLAND J;CHEN, JIAN JEFFREY;DEAL, JUDITH G
分类号 C07D233/58;A61K31/00;A61K31/34;A61K31/341;A61K31/38;A61K31/381;A61K31/40;A61K31/4025;A61K31/407;A61K31/415;A61K31/4164;A61K31/4178;A61K31/44;A61K31/4427;A61K31/443;A61K31/4433;A61K31/4436;A61K31/4439;A61K31/55;A61K38/00;A61P1/00;A61P1/02;A61P9/00;A61P9/10;A61P19/00;A61P19/02;A61P19/10;A61P29/00;A61P35/00;A61P43/00;C07D207/32;C07D207/327;C07D207/337;C07D231/12;C07D233/54;C07D233/56;C07D307/54;C07D333/24;C07D333/26;C07D401/04;C07D401/10;C07D401/12;C07D401/14;C07D403/12;C07D405/10;C07D405/12;C07D405/14;C07D409/12;C07D487/04;C07D487/08;C07D498/08;C07D521/00;C07K5/072;(IPC1-7):A61K31/40;A61K38/05;C07K5/078 主分类号 C07D233/58
代理机构 代理人
主权项
地址